AACR Annual Meeting 2021: A Recap of Blog Posts
The AACR Annual Meeting 2021 featured the theme “Discovery Science Driving Clinical Breakthroughs.” Indeed, over the course of two weeks,...
The AACR Annual Meeting 2021 featured the theme “Discovery Science Driving Clinical Breakthroughs.” Indeed, over the course of two weeks,...
There has been a rapid expansion of technology in recent years, from artificial intelligence to intensive genetic sequencing to...
The American Association for Cancer Research (AACR) Annual Meeting 2019 drew more than 21,000 attendees, providing a robust forum...
Guest Post by Raymond DuBois, MD, PhD Arizona State University Biodesign Institute
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
Breast cancer can be a scary diagnosis. Even though mortality rates have declined in recent years in the United...
Hear from AACR President Carlos L. Arteaga, MD, and Annual Meeting Program Committee Chairperson Lewis C. Cantley, PhD, about...
Supreme Court Justice Ruth Bader Ginsburg is not among us today. Sadly, we lost this iconic, trailblazing leader, who was the...
The flurry of anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) late last month included the...
Back for the new year, here are the editors’ selections for the January issues of the eight scientific journals...
Later this week, more than 200 researchers will convene in Montreal for a four-day conference on DNA Repair: Tumor...
For Bruce Hill, who was diagnosed with stage 4 clear cell renal cell carcinoma (RCC) in 2017, scientific progress...
A nine-valent HPV vaccine currently under FDA review may prevent nearly 90 percent of cervical cancers worldwide, but we...
Each month, the American Association for Cancer Research (AACR) publishes 10 articles from its eight esteemed scientific journals, showcasing...
Bladder cancer is a common malignancy originating in the bladder, a hollow organ located in the abdomen that stores urine. It is the sixth most prevalent cancer in the United...
Policymakers, parents, teachers, and public health professionals have all expressed concern about the rise in teen vaping and a...
The lung cancer death rate—the number of lung cancer deaths per 100,000 U.S. men and women—has been decreasing slowly...
In the ongoing quest to end cancer health disparities, there’s a simple tool that virtually anyone can use: honest...
This year marks the 10th anniversary of Cancer Discovery, a journal of the AACR. To celebrate the anniversary, Cancer Discovery published a special anniversary issue, featured spotlights on groundbreaking articles on its website, and held the Cancer Discovery ...
Cancer Today Senior Editor Marci A. Landsmann shares her experience reporting on a young lung cancer survivor, Emily Bennett...
On Wednesday, the American Association for Cancer Research (AACR) released its annual Cancer Progress Report. Now in its 11th year, the report details advances in the cancer research...
As the murders of George Floyd, Breonna Taylor, and others exposed racial inequities in America, many sectors of society...
A recent study in the AACR’s journal Cancer Epidemiology, Biomarkers & Prevention found an association between glycemic index (a...
The blog rounds up the 2023 SABCS, which had 10,874 in-person and virtual registrants and featured cutting-edge research, thoughtful...
The plenary program of the AACR Annual Meeting 2023 kicked off Saturday, April 15, with a session titled “Beating...
When Monica Bertagnolli, MD, was appointed director of the National Cancer Institute in 2022, she became the first woman...
Disparities in health care are among the most significant forms of inequality and injustice. In the United States, racial...
At the age of 40, Marlena Murphy was diagnosed with triple-negative breast cancer, an aggressive subtype that occurs twice...
The American Association for Cancer Research (AACR) applauds and commends President Obama and Vice President Biden for their dedication...
In the final weeks of 2018, the U.S. Food and Drug Administration (FDA) announced three approvals of anticancer therapeutics....